June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
EVALUATION OF READER AGREEMENT IN ASSESSMENT OF RETINAL IMAGES WITH RETINOPATHY OF PREMATURITY USING SOFTWARE ASSITANCE
Author Affiliations & Notes
  • E Simon Barriga
    VisionQuest Biomedical LLC, Albuquerque, NM
  • Carla Agurto Rios
    VisionQuest Biomedical LLC, Albuquerque, NM
  • Vinayak S Joshi
    VisionQuest Biomedical LLC, Albuquerque, NM
  • Cesar Carranza
    VisionQuest Biomedical LLC, Albuquerque, NM
    Electrical and Computer Engineering, University of New Mexico, Albuquerque, NM
  • G Baker Hubbard
    Emory Eye Center, Atlanta, GA
  • Sheila C Nemeth
    VisionQuest Biomedical LLC, Albuquerque, NM
  • Alejandro Aragon
    Instituto de Oftalmologia, Fundacion Conde de Valenciana, Mexico City, Mexico
  • Lorena Ramirez
    Instituto de Oftalmologia, Fundacion Conde de Valenciana, Mexico City, Mexico
  • Wendall Bauman
    Retina Institute of South Texas, San Antonio, TX
  • Antonio Capone
    Associated Retinal Consultants, Rochester, MI
  • Footnotes
    Commercial Relationships E Simon Barriga, VisionQuest Biomedical (E); Carla Agurto Rios, VisionQuest Biomedical (E); Vinayak Joshi, VisionQuest Biomedical (E); Cesar Carranza, VisionQuest Biomedical (F); G Hubbard, VisionQuest Biomedical (C); Sheila Nemeth, VisionQuest Biomedical (E); Alejandro Aragon, None; Lorena Ramirez, None; Wendall Bauman, VisionQuest Biomedical (I); Antonio Capone, VisionQuest Biomedical (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 972. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E Simon Barriga, Carla Agurto Rios, Vinayak S Joshi, Cesar Carranza, G Baker Hubbard, Sheila C Nemeth, Alejandro Aragon, Lorena Ramirez, Wendall Bauman, Antonio Capone; EVALUATION OF READER AGREEMENT IN ASSESSMENT OF RETINAL IMAGES WITH RETINOPATHY OF PREMATURITY USING SOFTWARE ASSITANCE. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):972. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate changes in reader variability for staging retinopathy of prematurity (ROP) and plus disease when using computer assisted tools for image grading

Methods: NeoScan is a software tool designed to provide image enhancement and quantitative measurements of retinal images from neonates aimed at reducing the number of inadequate images for quality and at reducing inter-reader variability. Quality and reading variability issues are hurdles to implementation of tele-ophthalmology solutions for ROP screening.<br /> To evaluate changes in reader variability, we performed a reading study with a retina specialist, a certified ophthalmic medical technician (COMT), and two ophthalmology residents. This group read images for twenty cases from the PHOTO-ROP study without NeoScan and then read the same dataset using NeoScan after a period of two weeks to three months. The graders evaluated the cases for quality, ROP stage, and plus disease.<br /> NeoScan has two software components: image enhancement and retinal vasculature assessment. For image enhancement three methods were combined: illumination correction, contrast limit adaptive histogram equalization, and anisotropic diffusion. For quantitative measurement of the retinal vasculature we calculated tortuosity and width for automatically segmented vessels. Tortuosity was calculated using a curvature-based method and vessel caliber was calculated by dividing the vessel into small segments of 15 pixels and measuring the width at every pixel cross section.

Results: There was a statistically significant reduction (p<0.02) in the amount of inadequate images for three out of the four readers. The average number of inadequate images decreased from 43% to 32%. When using NeoScan the COMT doubled her plus disease agreement coefficient (.29-.49) with the clinical ground truth. Also, the agreement coefficient for plus disease between the retina specialist and the COMT increased significantly, from 0.15 to 0.77 (p<0.05).

Conclusions: The reduction of inadequate images supports the readers’ assessment that NeoScan’s most useful feature was the image enhancement. The increased agreement in plus disease assessment between the retina specialist and the COMT indicates that NeoScan has a potential for reducing grading variability among experienced graders. A larger study needs to be conducted to confirm this hypothesis.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×